Journals / Haydarpaşa Numune Medical Journal / 2020 / Cilt: 60 - Sayı: 2

Refractive Results and Endothelial Safety of a Foldable Iris-claw Phakic Intraocular Lens

Pages
178–181
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

How-ever, a 5-year follow-up is not sufficient to evaluate its long term endothelial safety profile.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: To report long term results after foldable iris-claw phakic intraocular lens (pIOL) implantation for the treatment of high myopia.Methods: The medical records of patients who underwent Artiflex (Ophtec BV, Netherlands) or Veriflex (Abbott Medical Optics Inc., USA) pIOL were retrospectively analyzed.
📊
Key Findings & Data:The complications observed during and after surgery were also recorded.Results: This study included 23 eyes of the 23 patients.
💡
Conclusion & Impact:How-ever, a 5-year follow-up is not sufficient to evaluate its long term endothelial safety profile.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Introduction: To report long term results after foldable iris-claw phakic intraocular lens (pIOL) implantation for the treatment of high myopia.Methods: The medical records of patients who underwent Artiflex (Ophtec BV, Netherlands) or Veriflex (Abbott Medical Optics Inc., USA) pIOL were retrospectively analyzed. Patients with five years of follow-up were included in this study. Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and central endothelial cell density (ECD) were analyzed preoperatively and in five years after surgery. The complications observed during and after surgery were also recorded.Results: This study included 23 eyes of the 23 patients. Mean preoperative SE was -10.71D±2.84D and improved to -1.60D±0.80D at the postoperative 5-year visit. Mean preoperative and postoperative UDVA were 1.47±0.22 logMAR and 0.26±0.16 logMAR, respectively (p<0.05). Mean preoperative and postoperative CDVA were 0.26±0.15 logMAR and 0.17±0.12 logMAR, respectively (p<0.05). Mean ECD decreased from 2526±268 cells/mm2 to 2357±295 cells/mm2 in five years postop-eratively. (p<0.05) In two eyes, a temporary, steroid-induced increase in intraocular pressure (IOP) was detected.Discussion and Conclusion: Artiflex/Veriflex pIOL implantation was found safe and effective in five years after surgery. How-ever, a 5-year follow-up is not sufficient to evaluate its long term endothelial safety profile.

🔖

Cite This Article

ÇAKIR, İ., AĞCA, A., YAŞA, D., YILDIRIM, Y., YILDIZ, B. K., ERDOĞAN, M. G., DEMİROK, A. (2020). Refractive Results and Endothelial Safety of a Foldable Iris-claw Phakic Intraocular Lens. Haydarpaşa Numune Medical Journal, Cilt: 60 - Sayı: 2, 178–181. https://ajindex.com/articles/162383

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Bohac M, Anticic M, Draca N, Kozomara B, Dekaris I, Gabric N, et al. Comparison of Verisyse and Veriflex Phakic Intraocular Lenses for Treatment of Moderate to High Myopia 36 Months after Surgery. Semin Ophthalmol 2017;32:725–733
  2. Stulting RD, John ME, Maloney RK, Assil KK, Arrowsmith PN, Thompson VM; U.S. Verisyse Study Group. Three-year results of Artisan/Verisyse phakic intraocular lens implantation. Re-sults of the United States Food And Drug Administration clin-ical trial. Ophthalmology 2008;115:464–472.e1
  3. Dick HB, Budo C, Malecaze F, Güell JL, Marinho AA, Nuijts RM, et al. Foldable Artiflex phakic intraocular lens for the correc-tion of myopia: two-year follow-up results of a prospective European multicenter study. Ophthalmology 2009;116:671–7
  4. Özertürk Y, Kubaloglu A, Sari ES, Koytak A, Capkin M, Akçay L, et al. Foldable iris-fixated phakic intraocular lens implantation for the correction of myopia: two years of follow-up. Indian J Ophthalmol 2012;60:23–8
  5. Güell JL, Morral M, Gris O, Gaytan J, Sisquella M, Manero F. Five-year follow-up of 399 phakic Artisan-Verisyse implanta-tion for myopia, hyperopia, and/or astigmatism. Ophthalmol-ogy 2008;115:1002–12
  6. Kwon SW, Moon HS, Shyn KH. Visual improvement in high myopic amblyopic adult eyes following phakic anterior chamber intraocular lens implantation. Korean J Ophthalmol 2006;20:87–92
  7. Yaşa D, Ağca A, Alkın Z, Çankaya Kİ, Karaküçük Y, Coşar MG, et al. Two-Year Follow-Up of Artisan Iris-Supported Phakic Ante-rior Chamber Intraocular Lens for Correction of High Myopia. Semin Ophthalmol 2016;31:280–4
  8. Barequet IS, Wygnanski-Jaffe T, Hirsh A. Laser in situ ker-atomileusis improves visual acuity in some adult eyes with amblyopia. J Refract Surg 2004;20:25–8
  9. Tahzib NG, Nuijts RM, Wu WY, Budo CJ. Long-term study of Ar-tisan phakic intraocular lens implantation for the correction of moderate to high myopia: ten-year follow-up results. Oph-thalmology. 2007 Jun;114:1133–42
  10. Jonker SMR, Berendschot TTJM, Ronden AE, Saelens IEY, Bauer NJC, Nuijts RMMA. Long-Term Endothelial Cell Loss in Patients with Artisan Myopia and Artisan Toric Phakic Intraocular Lenses: 5- and 10-Year Results. Ophthalmology 2018;125:486–94
  11. Budo C, Hessloehl JC, Izak M, Luyten GP, Menezo JL, Sener BA, et al. Multicenter study of the Artisan phakic intraocular lens. J Cataract Refract Surg 2000;26:1163–71
  12. Chen Y, Liu Q, Xue C, Huang Z, Chen Y. Three-year follow-up of secondary anterior iris fixation o